Invivyd, Inc. (IVVD)
NASDAQ: IVVD · Real-Time Price · USD
1.140
+0.010 (0.88%)
At close: May 29, 2026, 4:00 PM EDT
1.160
+0.020 (1.75%)
After-hours: May 29, 2026, 7:40 PM EDT
Invivyd Market Cap
Invivyd has a market cap or net worth of $335.85 million as of May 29, 2026. Its market cap has increased by 225.20% in one year.
Market Cap
335.85M
Enterprise Value
160.33M
1-Year Change
225.20%
Ranking
Category
Stock Price
$1.14
Market Cap Chart
Since August 6, 2021, Invivyd's market cap has decreased from $2.27B to $335.85M, a decrease of -85.18%. That is a compound annual growth rate of -32.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 28, 2026 | 332.91M | -51.36% |
| Dec 31, 2025 | 684.49M | 1,191.45% |
| Dec 31, 2024 | 53.00M | -87.78% |
| Dec 29, 2023 | 433.85M | 165.40% |
| Dec 30, 2022 | 163.47M | -79.76% |
| Dec 31, 2021 | 807.69M | -64.36% |
| Aug 6, 2021 | 2.27B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fennec Pharmaceuticals | 343.55M |
| Neumora Therapeutics | 343.45M |
| Rezolute | 341.61M |
| DiaMedica Therapeutics | 331.92M |
| Lineage Cell Therapeutics | 331.57M |
| Nautilus Biotechnology | 330.41M |
| Rocket Pharmaceuticals | 329.76M |
| Abeona Therapeutics | 329.43M |